Stockscreener 앱 받기
22.61
1.30%
0.305
전일 마감가:
$22.31
열려 있는:
$22.5
하루 거래량:
28,814
Relative Volume:
0.14
시가총액:
$422.00M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+6.81%
1개월 성능:
-0.15%
6개월 성능:
-29.09%
1년 성능:
+40.11%
1일 변동 폭
$21.82
$23.12
1주일 범위
$20.00
$23.40
52주 변동 폭
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
TECX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
22.60 | 433.37M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
379.05 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
559.54 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.62 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
642.82 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.10 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-21 | 개시 | Mizuho | Outperform |
| 2024-11-20 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | TD Cowen | Buy |
| 2023-12-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-05 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-27 | 개시 | Needham | Buy |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2019-04-05 | 개시 | Janney | Buy |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-17 | 개시 | H.C. Wainwright | Buy |
| 2018-07-16 | 개시 | Wedbush | Outperform |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
모두보기
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Full technical analysis of Tectonic Therapeutic Inc. stockEarnings Report Summary with Market Impact - Newser
Regression analysis insights on Tectonic Therapeutic Inc. performanceBuy and Hold Position Summary Review - Newser
What does recent volatility data suggest for Tectonic Therapeutic Inc.Daily Pattern Analysis with Return Forecast - Newser
Combining machine learning predictions for Tectonic Therapeutic Inc.Day Trading Setup and Momentum Analysis - Newser
Risk adjusted return profile for Tectonic Therapeutic Inc. analyzedLow Risk Stock Selection Strategy Guide - Newser
How to escape a deep drawdown in Tectonic Therapeutic Inc.Intraday Strategy with Real Time Monitoring - Newser
What institutions are buying Tectonic Therapeutic Inc. stock nowWeekly Hot Stocks Based on Volume Flow - Newser
Using data models to predict Tectonic Therapeutic Inc. stock movementFree Oversold Bounce Stock Play Ideas - Newser
How moving averages guide Tectonic Therapeutic Inc. tradingAI Model Forecasting Reversal and Breakout Zones - Newser
What analysts say about Tectonic Therapeutic Inc. stock outlookRisk Adjusted Trade Signal Screening Tool - Newser
Is Tectonic Therapeutic Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Low Volatility Stable Growth Picks - Newser
Tectonic Therapeutic Inc. stock chart pattern explainedTechnical Reversal Setup with Risk Limits - Newser
Real time breakdown of Tectonic Therapeutic Inc. stock performanceMulti-Year Investment Performance Summary Report - Newser
Historical volatility pattern of Tectonic Therapeutic Inc. visualizedFree Weekly Hot Picks With Buy Confidence - Newser
How to forecast Tectonic Therapeutic Inc. trends using time seriesFast Entry Strategy with Price Prediction - Newser
Why Tectonic Therapeutic Inc. stock attracts strong analyst attentionMarket Correction Proof Stock Screening Analysis - Newser
Tectonic Therapeutic Inc. Reports Increased Cash Reserves - TipRanks
Tectonic (TECX) Q2 R&D Soars 142% - AOL.com
Tectonic (TECX) Q2 R&D Soars 142% - The Motley Fool
Tectonic Therapeutic Reports Q2 Financial Results - TipRanks
Risk vs reward if holding onto Tectonic Therapeutic Inc.Free Low Risk Buy Zone Opportunity Watch - Newser
Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Clinical Trial Success: TX45 Shows 19% PCWP Drop, Plans New PH-ILD Phase 2 Study - Stock Titan
Comparing Tectonic Therapeutic Inc. in custom built stock radarsStock Portfolio Risk and Return Analysis - Newser
How Tectonic Therapeutic Inc. stock performs during market volatilityWeekly Outlook for Short Term Investors - Newser
Sectors Driving Future Growth for Tectonic Therapeutic Inc. StockWeekly Trend Watch with Market Signals - Newser
Will Tectonic Therapeutic Inc. outperform the marketRisk-Managed Trade Alerts for Consistency - Newser
Using data filters to optimize entry into Tectonic Therapeutic Inc.High Reward Picks with Tight Risk Control - Newser
Tectonic Therapeutic Inc.’s volatility index tracking explainedTechnical Safety Zone Pattern Recognition - Newser
What makes Tectonic Therapeutic Inc. stock price move sharplyAI Powered Stock Trend Prediction Model - Newser
What is Tectonic Therapeutic Inc. company’s growth strategyOutstanding trading profits - Jammu Links News
Tectonic Therapeutic Inc (TECX) 재무 분석
Tectonic Therapeutic Inc (TECX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.07%
1.72%
자본화:
|
볼륨(24시간):